Clinical Trial Update: Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports Phase 2/3 results for dutasteride in reducing heavy drinking among adults with Alcohol Use Disorder, including analyses of pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Dutasteride (Avodart) (dutasteride)

Snippet

Sponsor: UConn Health | Conditions: Alcohol Use Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-05-09